Cholangiocarcinoma is a rare disease, with only two percent of patients with metastatic disease surviving past five years. But new funding is helping Cardiff University researchers to find out crucial information about this form of cancer.
Over £520,000 has been awarded to help fund world-leading blood stem cell research, which will have a long-lasting impact on bone marrow transplantation and blood transfusion.
Cardiff University has thanked the Leukaemia Research Appeal for Wales for 37 years of outstanding support, and for contributing more than £2.3 million to leukaemia research at the University over that time.
Over £130,000 has been awarded to researchers at the European Cancer Stem Cell Research Institute to fund innovative research into targeting pancreatic cancer.
Scientists at Cardiff University will be able to get an insight into aggressive brain cancer, thanks to a major investment from the Medical Research Council.
